About this trial
Pelvic Girdle Pain (PGP) is reported by 50% of pregnant women and up to 11 years after pregnancy, 10% of women have persistent and per definition chronic PGP. Central (nervous system) sensitization that elicits pain hypersensitivity, may be one explanation.
The overall aim of this study is to explore features of central sensitization in pregnant women and its predictive ability on physical activity, functioning and health in women with PGP. Measurements of central sensitization will be done on two study groups, pregnant women with PGP and healthy controls. To identify women at risk to develop chronic pain in relation to a common pain experience ie PGP in pregnancy, may help us understand if central sensitization early in life explains why women develop chronic pain.
Eligibility criteria
Qualifiers
pregnant (first time pregnant or previous experience of pregnancy)
18 years of age or older
have a single foetus pregnancy
be in gestational weeks 20-30
Disqualifiers
no history of a fracture or malignant disease in the back, pelvis, pelvic floor or hips
no systemic disease of the musculoskeletal or the nervous system
no diseases such as gestational diabetes or diabetes type 1 and 2, hypertension
no obstetric complications
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Göteborg University
Lead sponsor
Vastra Gotaland Region
Collaborator